Shenzhen Mindray sees double-digit growth in sales and net profit in 1H24, driven by in-vitro diagnostics and medical imaging systems. With 18% sales growth, international market outperforms China.
What is covered in the Full Insight:
Introduction to Shenzhen Mindray
Company Background and Global Presence
Financial Performance Highlights 1H24
Segment Analysis: International vs Domestic Markets
Research and Development Focus and Future Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.